ANN ARBOR, Mich., May 6 Accuri Cytometers Inc., a life sciences company manufacturing and marketing revolutionary bench-top flow cytometer systems, today announced the sale of the 500th unit of its ...

ANN ARBOR, Mich., July 12 /PRNewswire/ -- Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of ...

Technology that gives researchers the ability to quickly and precisely determine the number of cells with a given phenotype in cell cultures or fresh tissue samples is of great interest in diverse ...

The BD Accuri™ C6 is a personal flow cytometer that brings flow cytometry within reach by being easy to use, simple to maintain, and affordable. The analytical power and versatility of today’s ...

use cell analyzer that supports the use of any brand of tube, including microcentrifuge tubes, and 12 x 75 mm tubes made from polystyrene or polypropylene. The 2 laser system consists of the following ...

ANN ARBOR, Michigan — Accuri Cytometers, which makes low-cost bench-top cell analysis products, has raised $4 million to expand its manufacturing and customer service capabilities. The company said it ...

Accuri Cytometers Inc., today announced the 2009 recipients of its Accuri Flow Cytometer Creativity Awards program, which provides a free Accuri C6 Flow Cytometer® System each year to two sets of ...

ANN ARBOR, Mich., July 8 -- Accuri Cytometers Inc., a life sciences company developing revolutionary bench-top flow cytometer systems, today announced the completion of a $13 million Series C ...

HPV test will be combined with Accuri’s flow cytometer to identify those whose infection is progressing to cancer. IncellDx and Accuri Cytometers are coupling technologies to offer a cervical cancer ...

Baird Venture Partners (BVP), the U.S.-based venture capital fund of Baird Private Equity, announced today that its portfolio company Accuri Cytometers (Accuri) has signed a definitive agreement to be ...

Ann Arbor-based Accuri Cytometers Inc. announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures of Ann Arbor, Baird Venture ...